Why is Krebs Biochem falling/rising?

As of 15-Sep, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 75.00, reflecting a decrease of Rs 2.26 or 2.93%. The stock has underperformed its sector by 2.48% today and has fallen after three consecutive days of gains. It reached an intraday low of Rs 75, indicating weak trading activity, with a weighted average price suggesting more volume was traded near this low. Over the past week, the stock has shown a slight increase of 2.18%, but its longer-term performance is concerning, with a year-to-date decline of 18.92% and a staggering 38.78% drop over the last three years. The company has reported negative results for the last three consecutive quarters, with a negative book value and a weak long-term fundamental strength, which has contributed to the stock's recent downward movement.
In the broader market context, while the Sensex has gained 1.24% over the past week, Krebs Biochemicals has lagged significantly, highlighting its underperformance relative to the market. The stock's negative returns over the past year and three years, coupled with a high debt-to-equity ratio and declining sales, paint a troubling picture for investors. The falling investor participation, as evidenced by a 16.58% drop in delivery volume against the five-day average, further exacerbates the stock's challenges. Overall, the combination of poor financial performance, high debt levels, and negative market sentiment has led to the stock's decline.